Longeveron
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Longeveron and other ETFs, options, and stocks.About LGVN
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors.
CEOMohamed Wa’el Ahmed Hashad
CEOMohamed Wa’el Ahmed Hashad
Employees26
Employees26
HeadquartersMiami, Florida
HeadquartersMiami, Florida
Founded2014
Founded2014
Employees26
Employees26
LGVN Key Statistics
Market cap20.86M
Market cap20.86M
Price-Earnings ratio-0.50
Price-Earnings ratio-0.50
Dividend yield—
Dividend yield—
Average volume132.59K
Average volume132.59K
High today$1.40
High today$1.40
Low today$1.34
Low today$1.34
Open price$1.38
Open price$1.38
Volume75.36K
Volume75.36K
52 Week high$6.40
52 Week high$6.40
52 Week low$0.7707
52 Week low$0.7707
People also own
Based on the portfolios of people who own LGVN. This list is generated using Robinhood data, and it’s not a recommendation.